博士論文

Comparison of Canagliflozin, Dapagliflozin and Empagliflozin added to heart failure treatment in decompensated heart failure patients with type 2 diabetes mellitus

Icons representing 博士論文
The cover of this title could differ from library to library. Link to Help Page

Available in National Diet Library

Find on the publisher's website

国立国会図書館デジタルコレクション

Digital data available

Check on the publisher's website

Comparison of Canagliflozin, Dapagliflozin and Empagliflozin added to heart failure treatment in decompensated heart failure patients with type 2 diabetes mellitus

Persistent ID (NDL)
info:ndljp/pid/11659343
Material type
博士論文
Author
中垣内, 昌樹
Publisher
-
Publication date
2020-03-24
Material Format
Digital
Capacity, size, etc.
-
Name of awarding university/degree
富山大学,博士（医学）
View All

Notes on use at the National Diet Library

Notes on use

Note (General)：

富山大学・富医薬博甲第322号・中垣内 昌樹・2020/03/24構成論文Masaki Nakagaito, Shuji Joho, Ryuichi Ushijima, Makiko Nakamura, Koichiro Kinugawa, Comparison of Canagliflozin, ...

Search by Bookstore

Search by Bookstore

Read this material in an accessible format.

View materials in accessible formats for people with print disabilities (1Type)

Search by Bookstore

Read in Disability Resources

Bibliographic Record

You can check the details of this material, its authority (keywords that refer to materials on the same subject, author's name, etc.), etc.

Digital

Material Type
博士論文
Title
Comparison of Canagliflozin, Dapagliflozin and Empagliflozin added to heart failure treatment in decompensated heart failure patients with type 2 diabetes mellitus
Author/Editor
中垣内, 昌樹
Publication Date
2020-03-24
Publication Date (W3CDTF)
2020-03-24
Alternative Title
2型糖尿病を合併した非代償性心不全患者におけるカナグリフロジン、ダパグリフロジン、エンパグリフロジンの心不全への効果の比較
Degree grantor/type
富山大学
Date Granted
2020-03-24
Date Granted (W3CDTF)
2020-03-24
Dissertation Number
甲第322号